Page last updated: 2024-10-15

myxopyronin a

Description

myxopyronin A: from Myxococcus fulvus; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135455925
CHEMBL ID2204381
MeSH IDM0120133

Synonyms (15)

Synonym
myxopyronin a
carbamic acid, (5-(3-(2,5-dimethyl-1-oxo-2,4-octadienyl)-4-hydroxy-2-oxo-2h-pyran-6-yl)-1-hexenyl)-, methyl ester, (r-(e,e,e))-
88192-98-7
3DXJ
myxoporin a
CHEMBL2204381
NE6 ,
DTXSID501317768
carbamic acid, n-[(1e,5r)-5-[3-[(2e,4e)-2,5-dimethyl-1-oxo-2,4-octadien-1-yl]-4-hydroxy-2-oxo-2h-pyran-6-yl]-1-hexen-1-yl]-, methyl ester
methyl ((r,e)-5-(3-((2e,4e)-2,5-dimethylocta-2,4-dienoyl)-4-hydroxy-2-oxo-2h-pyran-6-yl)hex-1-en-1-yl)carbamate
AKOS040746143
V4A3T7BVQ8
carbamic acid, [(1e,5r)-5-[3-[(2e,4e)-2,5-dimethyl-1-oxo-2,4-octadienyl]-4-hydroxy-2-oxo-2h-pyran-6-yl]-1-hexenyl]-, methyl ester
carbamic acid, [5-[3-(2,5-dimethyl-1-oxo-2,4-octadienyl)-4-hydroxy-2-oxo-2h-pyran-6-yl]-1-hexenyl]-, methyl ester, [r-(e,e,e)]-
methyl n-[(1e,5r)-5-{3-[(2e,4e)-2,5-dimethylocta-2,4-dienoyl]-4-hydroxy-2-oxo-2h-pyran-6-yl}hex-1-en-1-yl]carbamate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain C, BACTERIAL RNA POLYMERASE BETA SUBUNIT; CHAIN C, MThermus thermophilus HB8Kd0.60000.60000.60000.6000AID977611
Chain D, BACTERIAL RNA POLYMERASE BETA-PRIME SUBUNIT; CHAIN D, NThermus thermophilus HB8Kd0.60000.60000.60000.6000AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2008Cell, Oct-17, Volume: 135, Issue:2
The RNA polymerase "switch region" is a target for inhibitors.
AID1668184Inhibition of recombinant Escherichia coli RNA polymerase2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Design, synthesis and biological evaluation of novel hybrids of N-aryl pyrrothine-base α-pyrone as bacterial RNA polymerase inhibitors.
AID713917Inhibition of Mycobacterium tuberculosis RNA polymerase2012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's7 (63.64)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (18.18%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]